Page last updated: 2024-08-23

lithium and alpha-synuclein

lithium has been researched along with alpha-synuclein in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, Z; Cook, LJ; Cordenier, A; Floto, RA; Imarisio, S; Pasco, M; Rubinsztein, DC; Sarkar, S	1
Bai, Y; Cheng, J; Liu, H; Tao, J; Xiao, Q; Zhao, Q; Zhu, Y	1
Guttuso, T	1

Reviews

1 review(s) available for lithium and alpha-synuclein

Article	Year
High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity. Medical hypotheses, 2019, Volume: 131 Topics: alpha-Synuclein; Alzheimer Disease; Autophagy; beta Catenin; beta-Glucosidase; Brain Chemistry; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Incidence; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lithium; Lithium Carbonate; Melanoma; Models, Biological; Mutation; Neuroprotective Agents; Nicotiana; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Parkinsonian Disorders; Smokers; Water; Wnt Signaling Pathway	2019

Article

Year

High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.

Medical hypotheses, 2019, Volume: 131

Topics: alpha-Synuclein; Alzheimer Disease; Autophagy; beta Catenin; beta-Glucosidase; Brain Chemistry; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Incidence; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lithium; Lithium Carbonate; Melanoma; Models, Biological; Mutation; Neuroprotective Agents; Nicotiana; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Parkinsonian Disorders; Smokers; Water; Wnt Signaling Pathway

2019

Other Studies

2 other study(ies) available for lithium and alpha-synuclein

Article	Year
Lithium induces autophagy by inhibiting inositol monophosphatase. The Journal of cell biology, 2005, Sep-26, Volume: 170, Issue:7 Topics: alpha-Synuclein; Animals; Autophagy; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Humans; Huntingtin Protein; Inositol; Lithium; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Phosphoric Monoester Hydrolases; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases	2005
Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson's disease via regulation of α‑synuclein methylation. Molecular medicine reports, 2019, Volume: 19, Issue:6 Topics: alpha-Synuclein; Animals; Behavior, Animal; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Introns; Lithium; Male; Methylation; Mice; Mice, Inbred C57BL; MicroRNAs; MPTP Poisoning; Neuroprotective Agents; Substantia Nigra	2019

Article

Year

Lithium induces autophagy by inhibiting inositol monophosphatase.

The Journal of cell biology, 2005, Sep-26, Volume: 170, Issue:7

Topics: alpha-Synuclein; Animals; Autophagy; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Humans; Huntingtin Protein; Inositol; Lithium; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Phosphoric Monoester Hydrolases; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases

2005

Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson's disease via regulation of α‑synuclein methylation.

Molecular medicine reports, 2019, Volume: 19, Issue:6

Topics: alpha-Synuclein; Animals; Behavior, Animal; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Introns; Lithium; Male; Methylation; Mice; Mice, Inbred C57BL; MicroRNAs; MPTP Poisoning; Neuroprotective Agents; Substantia Nigra

2019